Premium
Management of heart failure patients with COVID ‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology
Author(s) -
Zhang Yuhui,
Coats Andrew J.S.,
Zheng Zhe,
Adamo Marianna,
Ambrosio Giuseppe,
Anker Stefan D.,
Butler Javed,
Xu Dingli,
Mao Jingyuan,
Khan Muhammad Shahzeb,
Bai Ling,
Mebazaa Alexandre,
Ponikowski Piotr,
Tang Qizhu,
Ruschitzka Frank,
Seferovic Petar,
Tschöpe Carsten,
Zhang Shuyang,
Gao Chuanyu,
Zhou Shenghua,
Senni Michele,
Zhang Jian,
Metra Marco
Publication year - 2020
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.1915
Subject(s) - heart failure , medicine , pandemic , concomitant , intensive care medicine , covid-19 , disease , position paper , disease management , infectious disease (medical specialty) , pathology , parkinson's disease
The coronavirus disease 2019 (COVID‐19) pandemic of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection is causing considerable morbidity and mortality worldwide. Multiple reports have suggested that patients with heart failure (HF) are at a higher risk of severe disease and mortality with COVID‐19. Moreover, evaluating and treating HF patients with comorbid COVID‐19 represents a formidable clinical challenge as symptoms of both conditions may overlap and they may potentiate each other. Limited data exist regarding comprehensive management of HF patients with concomitant COVID‐19. Since these issues pose serious new challenges for clinicians worldwide, HF specialists must develop a structured approach to the care of patients with COVID‐19 and be included early in the care of these patients. Therefore, the Heart Failure Association of the European Society of Cardiology and the Chinese Heart Failure Association & National Heart Failure Committee conducted web‐based meetings to discuss these unique clinical challenges and reach a consensus opinion to help providers worldwide deliver better patient care. The main objective of this position paper is to outline the management of HF patients with concomitant COVID‐19 based on the available data and personal experiences of physicians from Asia, Europe and the United States.